QS Investors’s Kite Pharma, Inc. KITE Stock Holding History

QS Investors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,104	Closed	-$199K	–	2046
2017 Q3	$199K	Hold	1,104	–	–	﹤0.01%	1226
2017 Q2	$114K	Sell	1,104 -6	-0.5%	-$490	﹤0.01%	1370
2017 Q1	$87K	Buy	1,110 +1,092	+6,067%	+$67.5K	﹤0.01%	1416
2016 Q4	$1K	Buy	18 +11	+157%	+$540	﹤0.01%	1888
2016 Q3	$1K	Buy	7 +2	+40%	+$111	﹤0.01%	1887
2016 Q2	$1K	Sell	5 -5	-50%	-$246	﹤0.01%	1952
2016 Q1	$1K	Buy	10 +6	+150%	+$291	﹤0.01%	1914
2015 Q4	$1K	Buy	+4	New	+$282	﹤0.01%	1996

QS Investors's KITE Position: Q4 2017 in Review

QS Investors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,104 shares — an estimated $199K sold.

QS Investors first reported a position in KITE in Q4 2015 and held it in 8 quarters. The position peaked at $199K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

QS Investors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
QS Investors sold 1,104 Kite Pharma, Inc. shares in Q4 2017, an estimated $199K.
QS Investors first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 8 quarters.
QS Investors's Kite Pharma, Inc. position peaked at $199K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on QS Investors's 13F filing for Q4 2017, filed 14 Feb 2018.